Specific Strains of Faecalibacterium prausnitzii Ameliorate Nonalcoholic Fatty Liver Disease in Mice in Association with Gut Microbiota Regulation
Open Access
Abstract
Evidence linking Faecalibacterium prausnitzii abundance to nonalcoholic fatty liver disease (NAFLD) is accumulating; however, the causal relationship remains obscure. In this study, 12 F. prausnitzii strains were orally administered to high fat diet fed C57BL/6J mice for 12 weeks to evaluate the protective effects of F. prausnitzii on NAFLD. We found that five F. prausnitzii strains, A2-165, LB8, ZF21, PL45, and LC49, significantly restored serum lipid profiles and ameliorated glucose intolerance, adipose tissue dysfunction, hepatic steatosis, inflammation, and oxidative stress in a mouse model of NAFLD. Moreover, two strains, LC49 and LB8, significantly enhanced short-chain fatty acid (SCFA) production and modulated the gut microbiota. Based on the combined analysis of linear discriminant analysis effect size and microbial communities, the core microbiome related to NAFLD comprised Odoribacter, Roseburia, Erysipelatoclostridium, Tyzzerella, Faecalibaculum, Blautia, and Acetatifactor, and the last five genera can be reversed by treatment with the LC49 and LB8 strains. Additionally, the LC49 and LB8 strains enriched Lactobacillus, Ileibacterium, Faecalibacterium, Dubosiella, and Bifidobacterium and downregulated pathways involving carbohydrate metabolism, amino acid metabolism, and fatty acid biosynthesis. Interestingly, LC49 supplementation also upregulated tryptophan metabolism, glutathione metabolism, and valine, leucine, and isoleucine degradation, which might be related to NAFLD prevention. Collectively, F. prausnitzii LC49 and LB8 exerted considerable anti-NAFLD and microbiota-regulating effects, indicating their potential as probiotic agents for NAFLD treatment.Keywords
Funding Information
- project 111 (BP0719028), the National Natural Science Foundation of China (31820103010)
- the Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province (31820103010)
This publication has 61 references indexed in Scilit:
- Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat dietJournal of Bioscience and Bioengineering, 2014
- A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitisGut, 2013
- Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesNature Biotechnology, 2013
- Commensal bacteria at the interface of host metabolism and the immune systemNature Immunology, 2013
- The gut microbiota and the liver. Pathophysiological and clinical implicationsJournal of Hepatology, 2013
- Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal StudyPLOS ONE, 2013
- Functional interactions between the gut microbiota and host metabolismNature, 2012
- Pathogenesis of non-alcoholic fatty liver diseaseQJM: An International Journal of Medicine, 2009
- Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in MiceDiabetes, 2009
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsProceedings of the National Academy of Sciences, 2008